Although impairment or decreased expression of DDAH2 has been reported in several diseases such as chronic kidney disease, pulmonary hypertension, and cardiovascular disease [18–22], the association of DDAH2 with malignancy has received less attention. The gene discussed is DDAH2; the disease is chronic kidney disease.